The biological activity of auranofin: implications for novel treatment of diseases
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The biological activity of auranofin: implications for novel treatment of diseases
Authors
Keywords
-
Journal
INFLAMMOPHARMACOLOGY
Volume 20, Issue 6, Pages 297-306
Publisher
Springer Nature
Online
2012-09-10
DOI
10.1007/s10787-012-0149-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
- (2012) Anjan Debnath et al. NATURE MEDICINE
- Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension
- (2011) Mark G. Lewis et al. AIDS
- Investigation of a potential mechanism for the inhibition of SmTGR by Auranofin and its implications for Plasmodium falciparum inhibition
- (2011) Antonia Caroli et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Clostridium difficile infection
- (2011) Andrea Lo Vecchio et al. CURRENT OPINION IN GASTROENTEROLOGY
- Thioredoxin Reductase-2 Is Essential for Keeping Low Levels of H2O2Emission from Isolated Heart Mitochondria
- (2011) Brian A. Stanley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Auranofin protects against cocaine-induced hepatic injury through induction of heme oxygenase-1
- (2011) Takashi Ashino et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Gold compounds as therapeutic agents for human diseases
- (2011) Susan J. Berners-Price et al. Metallomics
- Auranofin Protects against Anthrax Lethal Toxin-Induced Activation of the Nlrp1b Inflammasome
- (2010) Zachary L. Newman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin
- (2010) Se-Jeong Park et al. ARCHIVES OF PHARMACAL RESEARCH
- HIV therapeutic possibilities of gold compounds
- (2010) Pascaline N. Fonteh et al. BIOMETALS
- Mitochondrial respiratory chain involvement in peroxiredoxin 3 oxidation by phenethyl isothiocyanate and auranofin
- (2010) Kristin K. Brown et al. FEBS LETTERS
- Auranofin, a Gold(I)-Containing Antirheumatic Compound, Activates Keap1/Nrf2 Signaling via Rac1/iNOS Signal and Mitogen-Activated Protein Kinase Activation
- (2010) Nam-Hoon Kim et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity
- (2010) Aya Nakaya et al. LEUKEMIA RESEARCH
- In vitro killing action of auranofin on Taenia crassiceps metacestode (cysticerci) and inactivation of thioredoxin–glutathione reductase (TGR)
- (2010) José J. Martínez-González et al. PARASITOLOGY RESEARCH
- Inhibition of Selenium Metabolism in the Oral Pathogen Treponema denticola
- (2009) S. Jackson-Rosario et al. JOURNAL OF BACTERIOLOGY
- Free Thiol Group of MD-2 as the Target for Inhibition of the Lipopolysaccharide-induced Cell Activation
- (2009) Mateja Manček-Keber et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition ofSchistosoma mansoniThioredoxin-glutathione Reductase by Auranofin
- (2009) Francesco Angelucci et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Auranofin disrupts selenium metabolism in Clostridium difficile by forming a stable Au–Se adduct
- (2009) Sarah Jackson-Rosario et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
- (2009) Nicolas Chomont et al. NATURE MEDICINE
- The Heart Is an Early Target of Anthrax Lethal Toxin in Mice: A Protective Role for Neuronal Nitric Oxide Synthase (nNOS)
- (2009) Mahtab Moayeri et al. PLoS Pathogens
- Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages
- (2008) Shinha Han et al. ARCHIVES OF PHARMACAL RESEARCH
- The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation
- (2008) Andrew G. Cox et al. BIOCHEMICAL PHARMACOLOGY
- Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia
- (2008) S Talbot et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Influence of Auranofin, a Clinically Established Antiarthritic Gold Drug, on Bone Metabolism: Analysis of Its Effects on Human Multipotent Adipose-Derived Stem Cells, Taken as a Model
- (2008) Chiara Chiellini et al. CHEMISTRY & BIODIVERSITY
- New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro : Mechanistic and pharmacological implications
- (2008) Anna Rosa Sannella et al. FEBS LETTERS
- Platyhelminth Mitochondrial and Cytosolic Redox Homeostasis Is Controlled by a Single Thioredoxin Glutathione Reductase and Dependent on Selenium and Glutathione
- (2008) Mariana Bonilla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Malaria research in the post-genomic era
- (2008) Elizabeth Ann Winzeler NATURE
- Clinical pharmacology of gold
- (2008) W. F. Kean et al. INFLAMMOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now